| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/10/2013 | WO2012177756A3 Non-leaching antimicrobial wound dressing |
| 05/10/2013 | WO2012170504A3 Treatment of extracellular matrix to reduce inflammation |
| 05/10/2013 | WO2012156317A3 Intranasal pharmaceutical dosage forms comprising naloxone |
| 05/10/2013 | WO2012154704A9 System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings |
| 05/10/2013 | WO2012088304A3 Two-piece injectable drug delivery device with heat-cured seal |
| 05/10/2013 | WO2009156014A8 Bitablets comprising compacted polyallylamine polymer and method for the production thereof |
| 05/10/2013 | CA2854449A1 Stable dermatological aerosol foams utilizing reactive propellants |
| 05/10/2013 | CA2854430A1 Liposomal corticosteroids for treatment of inflammatory disorders in humans |
| 05/10/2013 | CA2854361A1 Subcutaneous delivery of polymer conjugates of therapeutic agents |
| 05/10/2013 | CA2854164A1 Dermal delivery compositions and methods |
| 05/10/2013 | CA2853966A1 Multisomes: encapsulated droplet networks |
| 05/10/2013 | CA2853949A1 Methods for treating cancers using oral formulations of cytidine analogs |
| 05/10/2013 | CA2853942A1 Formulations for the treatment of diabetes |
| 05/10/2013 | CA2853713A1 Osmotically active vaginal delivery system |
| 05/10/2013 | CA2853685A1 Single use system for sterilely producing lipid-nucleic acid particles |
| 05/10/2013 | CA2853470A1 Nano-suspension process |
| 05/10/2013 | CA2853235A1 Ophthalmological aqueous composition |
| 05/10/2013 | CA2853233A1 Ophthalmological aqueous composition |
| 05/10/2013 | CA2852564A1 Combinational liposome compositions for cancer therapy |
| 05/10/2013 | CA2851996A1 Pharmaceutical compositions for substituted quinazolinones |
| 05/10/2013 | CA2851327A1 Pharmaceutical composition of omeprazole |
| 05/10/2013 | CA2794445A1 Organogel compositions comprising alkylated benzimidazolones |
| 05/09/2013 | US20130116427 Cellulose interpolymers and method of oxidation |
| 05/09/2013 | US20130116426 Cellulose interpolymers and method of oxidation |
| 05/09/2013 | US20130116425 Cellulose interpolymers and method of oxidation |
| 05/09/2013 | US20130116327 Burst Drug Release Compositions |
| 05/09/2013 | US20130116316 Solid Pharmaceutical Compositions Containing Benzofuran Derivatives |
| 05/09/2013 | US20130116244 Pharmaceutical powder compositions |
| 05/09/2013 | US20130116239 Ivabradine-containing pharmaceutical composition with modified release |
| 05/09/2013 | US20130116210 Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| 05/09/2013 | US20130116178 Pharmaceutical compositions comprising polyethylene glycol having a molecular weight of less than 600 daltons |
| 05/09/2013 | US20130115321 Therapeutic agent for intranasal administration and method of making and using same |
| 05/09/2013 | US20130115320 Therapeutic agent for intranasal administration and method of making and using same |
| 05/09/2013 | US20130115318 Cosmetic composition containing a cypress essential oil complex as an active ingredient for enhancing memory and improving cognitive dysfunction |
| 05/09/2013 | US20130115305 Microemulsions and its use for preventing airway diseases |
| 05/09/2013 | US20130115302 Polysaccharide micro-particle encapsulatin growth factor |
| 05/09/2013 | US20130115301 Coating of particles comprising a pharmaceutically active ingredient with a carbonate salt or phosphate salt |
| 05/09/2013 | US20130115300 Ciprofloxacin dry syrup composition |
| 05/09/2013 | US20130115299 Method for inhibiting cancer stem cell like properties and chemoradioresistant properties of cancer or tumor cells with microrna145 |
| 05/09/2013 | US20130115298 Extended release compositions comprising as active compound venlafaxine hydrochloride |
| 05/09/2013 | US20130115297 Stable, durable granules with active agents |
| 05/09/2013 | US20130115294 Stable liquid oily ready-to-use formulations, preparation thereof and use thereof |
| 05/09/2013 | US20130115293 Therapeutic Polymeric Nanoparticles Comprising Corticosteroids and Methods of Making and Using Same |
| 05/09/2013 | US20130115292 Enteric tablet |
| 05/09/2013 | US20130115291 Enteric tablet |
| 05/09/2013 | US20130115290 Compositions for the symptomatic relief of stomach pain or gastrooesophageal reflux |
| 05/09/2013 | US20130115289 Anti-flush compositions |
| 05/09/2013 | US20130115288 Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1h)-pyridone |
| 05/09/2013 | US20130115287 Intraorally disintegrating tablet |
| 05/09/2013 | US20130115284 Omega3 fatty acid compound preparation |
| 05/09/2013 | US20130115283 Solid naproxen concentrates and related dosage forms |
| 05/09/2013 | US20130115282 Polyvalent polymeric matrix for modified release solid oral preparations and method of preparation thereof |
| 05/09/2013 | US20130115281 Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation |
| 05/09/2013 | US20130115278 Peptide Epitopes of Apolipoprotein B |
| 05/09/2013 | US20130115277 Peptide Epitopes of Apolipoprotein B |
| 05/09/2013 | US20130115276 Peptide Epitopes of Apolipoprotein B |
| 05/09/2013 | US20130115275 Peptide Epitopes of Apolipoprotein B |
| 05/09/2013 | US20130115274 Method of producing lipid nanoparticles for drug delivery |
| 05/09/2013 | US20130115273 Combinational Liposome Compositions for Cancer Therapy |
| 05/09/2013 | US20130115270 Anti-interleukin-1 (IL-1) antibody used as a targeting agent to treat arthritis and other diseases |
| 05/09/2013 | US20130115269 Anti-tumor necrosis factor alpha (TNF-a) antibody used as a targeting agent to treat arthritis and other diseases |
| 05/09/2013 | US20130115268 Methods of Administering a Dermatological Agent to a Subject |
| 05/09/2013 | US20130115266 Edible wafer-type product for delivery of nutraceuticals and pharmaceuticals |
| 05/09/2013 | US20130115265 Drug delivery system |
| 05/09/2013 | US20130115262 Substrate having an electron donating surface with metal particles comprising palladium on said surface |
| 05/09/2013 | US20130115255 Particulate Tissue Graft with Components of Differing Density and Methods of Making and Using the Same |
| 05/09/2013 | US20130115254 Aptamer-loaded, biocompatible nanoconstructs for nuclear-targeted cancer therapy |
| 05/09/2013 | US20130115252 Genipin-Rich Material and Its Use |
| 05/09/2013 | US20130115250 Burst Drug Release Compositions |
| 05/09/2013 | US20130115249 Osmotic Device Containing Amantadine and an Osmotic Salt |
| 05/09/2013 | US20130115247 Virion Derived Protein Nanoparticles For Delivering Radioisotopes For The Diagnosis And Treatment Of Malignant And Systemic Disease And The Monitoring Of Therapy |
| 05/09/2013 | US20130115246 Reduced dose oral pharmaceutical compositions of fenofibrate |
| 05/09/2013 | US20130115211 Cytokine antagonists for neurological and neuropsychiatric disorders |
| 05/09/2013 | US20130115196 Hybrid hydrogel scaffold compositions and methods of use |
| 05/09/2013 | US20130115181 Aqueous pharmaceutical system for the administration of drugs to the nails |
| 05/09/2013 | US20130115173 Stable Dermatological Aerosol Foams Utilizing Reactive Propellants |
| 05/09/2013 | US20130115169 Red blood cell-mimetic particles and methods for making use thereof |
| 05/09/2013 | US20130115165 Water-Dispersible Oral, Parenteral, and Topical Formulations for Poorly Water Soluble Drugs Using Smart Polymeric |
| 05/09/2013 | US20130113129 Enzyme Delivery Systems and Methods of Preparation and Use |
| 05/09/2013 | US20130112200 Sealed capsule including an integrated puncturing mechanism |
| 05/08/2013 | EP2589692A1 Nanofibre laminate sheet |
| 05/08/2013 | EP2589618A1 Composite particles which contain both cellulose and inorganic compound |
| 05/08/2013 | EP2589391A2 Method for treating and diagnosing cancer by using cell-derived microvesicles |
| 05/08/2013 | EP2589388A1 Use of a Teichoic acid for the treatment of malignant ascites |
| 05/08/2013 | EP2589387A1 Use of a teichoic acid for the treatment of malignant liquor cerebrospinalis in the brain |
| 05/08/2013 | EP2589384A1 New Pharmaceutical Compositions for the Treatment of Hyper-Proliferative Disorders |
| 05/08/2013 | EP2589380A2 Method for producing an electricity-conducting thread, textile structure for a transdermal active ingredient reservoir and method for storing active ingredient |
| 05/08/2013 | EP2589379A2 Transdermal drug delivery system containing donepezil |
| 05/08/2013 | EP2589378A1 Coating of cetyl myristate and/or cetyl palmitate particles |
| 05/08/2013 | EP2589377A2 Microvesicles derived from cell protoplast, and use thereof |
| 05/08/2013 | EP2589376A1 Oral disintegrating composition of anti-histamine agents |
| 05/08/2013 | EP2589366A1 Biodegradable film packaging for oral biologicals |
| 05/08/2013 | EP2588659A1 Filaments comprising an ingestible active agent nonwoven webs and methods for making same |
| 05/08/2013 | EP2588141A2 Antibody formulations |
| 05/08/2013 | EP2588140A2 Dental composites comprising nanoparticles of amorphous calcium phosphate |
| 05/08/2013 | EP2588135A2 Nanoemulsion vaccines |
| 05/08/2013 | EP2588132A2 Methods and compositions for cns delivery of -galactocerebrosidase |
| 05/08/2013 | EP2588130A1 Cns delivery of therapeutic agents |
| 05/08/2013 | EP2588128A1 Lactoferrin sequences, compositions and methods of corneal wound treatment |
| 05/08/2013 | EP2588125A2 Functional vascularization with biocompatible polysaccharide-based hydrogels |